Gambaran Umum
Immuron Limited, based in Australia, operates within the biopharmaceutical sector, chiefly focusing on the development and commercialization of oral immunotherapeutics for the treatment of gut pathologies. The company's innovative technology platform leverages bovine colostrum enriched with specific immunoglobulins to target and neutralize gut pathogens. A prominent project in Immuron’s portfolio is its flagship product, Travelan, which is designed to prevent travelers’ diarrhea. Additionally, the company is advancing clinical research on IMM-124E for addressing non-alcoholic steatohepatitis (NASH), a significant form of liver disease, along with other gastrointestinal and liver diseases. Immuron's strategic initiatives reflect a commitment to addressing significant unmet medical needs through biotherapeutic advancements.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Immuron Limited per 2025 Jun 30 adalah 7.29 MM.
- Nilai operating income untuk Immuron Limited per 2025 Jun 30 adalah -5.39 MM.
- Nilai net income untuk Immuron Limited per 2025 Jun 30 adalah -5.25 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 7.29 | -5.39 | -5.25 |
2025-03-31 | 6.91 | -5.48 | -6.30 |
2024-12-31 | 6.54 | -5.73 | -7.35 |
2024-09-30 | 5.72 | -5.48 | -7.14 |
2024-06-30 | 4.90 | -5.22 | -6.94 |
2024-03-31 | 4.24 | -4.47 | -5.41 |
2023-12-31 | 3.58 | -3.56 | -3.88 |
2023-09-30 | 2.69 | -3.48 | -3.83 |
2023-06-30 | 1.80 | -3.41 | -3.79 |
2023-03-31 | 1.46 | -3.32 | -3.40 |
2022-12-31 | 1.12 | -2.91 | -3.02 |
2022-09-30 | 0.94 | -2.94 | -2.94 |
2022-06-30 | 0.77 | -3.12 | -2.85 |
2022-03-31 | 0.56 | -3.82 | -3.66 |
2021-12-31 | 0.36 | -4.68 | -4.46 |
2021-09-30 | 0.25 | -6.32 | -6.42 |
2021-06-30 | 0.15 | -7.96 | -8.38 |
2021-03-31 | 0.56 | -7.33 | -7.76 |
2020-12-31 | 0.98 | -6.70 | -7.14 |
2020-09-30 | 1.75 | -4.88 | -5.04 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -0.03 | -0.03 |
2024-09-30 | -0.03 | -0.03 |
2024-06-30 | -0.03 | |
2024-03-31 | -0.02 | -0.02 |
2023-12-31 | -0.02 | -0.02 |
2023-09-30 | -0.02 | -0.02 |
2023-06-30 | -0.02 | |
2023-03-31 | -0.01 | -0.01 |
2022-12-31 | -0.01 | -0.01 |
2022-09-30 | -0.01 | -0.01 |
2022-06-30 | -0.01 | |
2022-03-31 | -0.02 | -0.02 |
2021-12-31 | -0.02 | -0.02 |
2021-09-30 | -0.03 | -0.03 |
2021-06-30 | -0.04 | |
2021-03-31 | -0.04 | -0.04 |
2020-12-31 | -0.04 | -0.04 |
2020-09-30 | -0.03 | -0.03 |
2020-06-30 | -0.02 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Immuron Limited per 2025 Jun 30 adalah -6.14 MM.
- Nilai cash from investing activities untuk Immuron Limited per 2025 Jun 30 adalah -2.90 MM.
- Nilai kas dari aktivitas pendanaan untuk Immuron Limited per 2025 Jun 30 adalah 0.20 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -6.14 | -2.90 | 0.20 |
2025-03-31 | -7.00 | -1.34 | 0.09 |
2024-12-31 | -7.87 | 0.23 | -0.02 |
2024-09-30 | -6.87 | 0.28 | -0.01 |
2024-06-30 | -5.88 | 0.33 | 0.00 |
2024-03-31 | -4.74 | 0.23 | -0.02 |
2023-12-31 | -3.61 | 0.14 | -0.05 |
2023-09-30 | -3.10 | -1.24 | -0.05 |
2023-06-30 | -2.60 | -2.62 | -0.04 |
2023-03-31 | -2.20 | -2.61 | -0.04 |
2022-12-31 | -1.81 | -2.60 | -0.04 |
2022-09-30 | -2.48 | -1.29 | -0.04 |
2022-06-30 | -3.15 | 0.01 | -0.04 |
2022-03-31 | -3.42 | 0.01 | -0.09 |
2021-12-31 | -3.70 | 0.01 | -0.14 |
2021-09-30 | -3.89 | 0.01 | 13.17 |
2021-06-30 | -4.08 | 0.00 | 26.48 |
2021-03-31 | |||
2020-12-31 | -4.29 | -0.00 | 26.50 |
2020-09-30 | -3.72 | -0.00 | 13.83 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Immuron Limited pada 2025 Jun 30 adalah -2.07.
- p/libro untuk Immuron Limited pada 2025 Jun 30 adalah 1.38.
- p/tbv untuk Immuron Limited pada 2025 Jun 30 adalah 1.47.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -2.07 | 1.38 | 1.47 |
2025-03-31 | -2.19 | 1.56 | 1.56 |
2024-12-31 | -2.61 | 1.42 | 1.42 |
2024-09-30 | -2.43 | 1.33 | 1.33 |
2024-06-30 | -4.45 | ||
2024-03-31 | -4.45 | ||
2023-12-31 | -4.57 | 0.88 | 0.88 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | -6.13 | 1.13 | 1.13 |
2021-12-31 | -2.72 | 0.88 | 0.88 |
2021-09-30 | -3.93 | 1.27 | 1.27 |
2021-06-30 | -2.06 | 0.67 | 0.67 |
2021-03-31 | -2.23 | 0.67 | 0.67 |
2020-12-31 | -2.41 | 0.60 | 0.60 |
2020-09-30 | -3.38 | 0.60 | 0.60 |
2020-06-30 | -4.63 | 2.40 | 2.40 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Immuron Limited pada 2025 Jun 30 adalah -1.13.
- EBIT (3 tahun) / EV untuk Immuron Limited pada 2025 Jun 30 adalah -0.92.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -1.13 | -0.92 |
2025-03-31 | -0.88 | -0.64 |
2024-12-31 | -1.08 | -0.72 |
2024-09-30 | -1.33 | -0.88 |
2024-06-30 | -0.22 | -0.07 |
2024-03-31 | -0.22 | -0.07 |
2023-12-31 | -24.76 | -28.66 |
2023-09-30 | -6.22 | -8.23 |
2023-06-30 | 2.17 | 3.42 |
2023-03-31 | 2.17 | 3.46 |
2022-12-31 | 1.13 | 1.89 |
2022-09-30 | 1.13 | 1.89 |
2022-06-30 | 0.93 | 1.10 |
2022-03-31 | -0.98 | -1.17 |
2021-12-31 | 3.70 | 2.95 |
2021-09-30 | -1.06 | -0.76 |
2021-06-30 | 1.09 | 0.69 |
2021-03-31 | 1.01 | 0.66 |
2020-12-31 | 0.78 | 0.53 |
2020-09-30 | 0.54 | 0.45 |
2020-06-30 | -0.28 | -0.34 |
Efektivitas Manajemen
- roa untuk Immuron Limited pada 2025 Jun 30 adalah -0.47.
- roe untuk Immuron Limited pada 2025 Jun 30 adalah -0.41.
- roic untuk Immuron Limited pada 2025 Jun 30 adalah -0.70.
- croic untuk Immuron Limited pada 2025 Jun 30 adalah -0.71.
- ocroic untuk Immuron Limited pada 2025 Jun 30 adalah -0.75.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.47 | -0.41 | -0.70 | -0.71 | -0.75 |
2025-03-31 | -0.47 | -0.50 | -0.70 | -0.71 | -0.75 |
2024-12-31 | -0.35 | -0.42 | -0.54 | -0.43 | -0.46 |
2024-09-30 | -0.35 | -0.41 | -0.54 | -0.43 | -0.46 |
2024-06-30 | -0.17 | ||||
2024-03-31 | -0.17 | ||||
2023-12-31 | -0.16 | -0.18 | -0.19 | -0.21 | -0.16 |
2023-09-30 | -0.15 | -0.16 | -0.19 | -0.25 | -0.13 |
2023-06-30 | -0.12 | -0.16 | -0.19 | -0.25 | -0.13 |
2023-03-31 | -0.12 | -0.15 | -0.17 | -0.23 | -0.11 |
2022-12-31 | -0.11 | -0.12 | -0.14 | -0.17 | -0.12 |
2022-09-30 | -0.11 | -0.12 | -0.14 | -0.17 | -0.12 |
2022-06-30 | -0.16 | -0.11 | -0.12 | -0.13 | -0.13 |
2022-03-31 | -0.16 | -0.14 | -0.16 | -0.14 | -0.15 |
2021-12-31 | -0.29 | -0.16 | -0.18 | -0.15 | -0.16 |
2021-09-30 | -0.22 | -0.22 | -0.27 | 0.37 | -0.16 |
2021-06-30 | -1.35 | -1.49 | -0.32 | 0.84 | -0.16 |
2021-03-31 | -1.25 | -1.37 | -0.30 | 0.83 | -0.16 |
2020-12-31 | -0.85 | -1.04 | -0.25 | 0.75 | -0.15 |
2020-09-30 | -0.60 | -0.74 | -0.18 | 0.34 | -0.13 |
2020-06-30 | -0.34 | -0.40 | -0.50 | -0.32 | -0.54 |
Gross Margins
- marjin kotor untuk Immuron Limited pada 2025 Jun 30 adalah 0.67.
- marjin bersih untuk Immuron Limited pada 2025 Jun 30 adalah -1.12.
- marjin operasi untuk Immuron Limited pada 2025 Jun 30 adalah -0.88.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.67 | -1.12 | -0.88 |
2025-03-31 | 0.67 | -1.12 | -0.88 |
2024-12-31 | 0.68 | -1.41 | -1.06 |
2024-09-30 | 0.68 | -1.41 | -1.06 |
2024-06-30 | 0.96 | -2.10 | -1.89 |
2024-03-31 | 0.96 | -2.10 | -1.89 |
2023-12-31 | 0.96 | -2.10 | -1.89 |
2023-09-30 | 0.96 | -2.10 | -1.89 |
2023-06-30 | 0.90 | -2.10 | -1.89 |
2023-03-31 | 0.90 | -2.33 | -2.22 |
2022-12-31 | 0.68 | -3.12 | -3.29 |
2022-09-30 | 0.68 | -3.12 | -3.29 |
2022-06-30 | -1.48 | -3.73 | -4.07 |
2022-03-31 | -1.48 | -6.52 | -6.84 |
2021-12-31 | -4.56 | -12.50 | -13.13 |
2021-09-30 | -4.56 | -25.57 | -25.17 |
2021-06-30 | -4.56 | -57.52 | -54.60 |
2021-03-31 | -0.13 | -13.74 | -12.82 |
2020-12-31 | 0.52 | -7.27 | -6.69 |
2020-09-30 | 0.67 | -2.88 | -2.76 |
2020-06-30 | 0.73 | -1.16 | -1.22 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1660046 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |